Search

everythinglearnresearchcommunity

for

Search:↓

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Choose oral contraceptives with specific side effects to manage issues like acne and avoid unwanted effects.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Acne is caused by increased sebum, abnormal skin shedding, bacteria, and inflammation, not dirt; treatments vary from creams to antibiotics or isotretinoin, with severe cases needing a dermatologist's care.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.